Pregnant Pause? Not for IBD Care—A Single Tertiary Care Center Prospective Cohort Study Affirming IBD Management in Pregnancy
Open Access
- 10 April 2025
- journal article
- Published by Oxford University Press (OUP) in Crohn's & Colitis 360
- Vol. 7 (2) , otaf029
Abstract
Background: This study examined Inflammatory Bowel Disease (IBD) management and outcomes during pregnancy in a tertiary care setting, focusing on disease activity, medication use, and maternal and neonatal outcomes. Methods: A prospective cohort study followed 287 women with IBD through 291 pregnancies from 2017 to 2023 at a single tertiary care center, collecting data preconception, during each trimester, and postpartum. Results: The study observed a 92.7% live birth rate. Seventy-four percent of individuals were in clinical remission preconception, and disease activity increased throughout pregnancy, particularly in ulcerative colitis (UC) patients (peaking at 37% in the second trimester), while remaining stable in CD patients. UC, disease duration <5 years, and preconception activity correlated with higher disease activity during pregnancy. Biologic use remained stable without significant impact on outcomes. Preterm delivery (6.7%) and small for gestational age infants (7%) rates reflected baseline population risk. Steroid use was associated with higher preterm delivery rates. Gestational hypertension (6.9%) and diabetes (9.4%) rates were similar to population norms. Maternal adverse events were higher in women 40 or older (OR 3.893). Conclusions: This study reaffirms the safety of continued medical therapy for IBD throughout pregnancy in a tertiary care, prospective cohort. Increased disease activity throughout pregnancy was evident, particularly in UC. Despite higher rates of disease activity amongst those with UC, outcomes were similar in those with CD vs UC—suggesting that disease activity measures have limitations in CD and pregnancy, or there is some mild inherent risk of CD in pregnancy outcomes irrespective of disease activity.Keywords
Funding Information
- GI Research Institute in Vancouver
This publication has 25 references indexed in Scilit:
- Predictors of Cesarean Delivery in Pregnant Women with Inflammatory Bowel DiseaseJournal of the Canadian Association of Gastroenterology, 2018
- Inflammatory Bowel Disease and Risk of Adverse Pregnancy OutcomesPLOS ONE, 2015
- Intrapartum Corticosteroid use Significantly Increases the Risk of Gestational Diabetes in Women with Inflammatory Bowel DiseaseJournal of Crohn's and Colitis, 2015
- Pregnancy related issues in inflammatory bowel disease: Evidence base and patients' perspectiveWorld Journal of Gastroenterology, 2012
- Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from JapanJournal of Crohn's and Colitis, 2011
- Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and SwedenInflammatory Bowel Diseases, 2011
- Pregnancy and IBD treatment: This challenging interplay from a patients' perspectiveJournal of Crohn's and Colitis, 2010
- A meta-analysis on the influence of inflammatory bowel disease on pregnancyGut, 2006
- Crohn's Disease and PregnancyBMJ, 1972
- ULCERATIVE COLITIS AND PREGNANCYThe Lancet, 1965